首页> 外文期刊>Trials >Improving recruitment to a study of telehealth management for long-term conditions in primary care: two embedded, randomised controlled trials of optimised patient information materials
【24h】

Improving recruitment to a study of telehealth management for long-term conditions in primary care: two embedded, randomised controlled trials of optimised patient information materials

机译:改善对初级保健中长期状况的远程医疗管理研究的招聘:两项针对患者的最佳信息材料的嵌入式,随机对照试验

获取原文
           

摘要

Background Patient understanding of study information is fundamental to gaining informed consent to take part in a randomised controlled trial. In order to meet the requirements of research ethics committees, patient information materials can be long and need to communicate complex messages. There is concern that standard approaches to providing patient information may deter potential participants from taking part in trials. The Systematic Techniques for Assisting Recruitment to Trials (MRC-START) research programme aims to test interventions to improve trial recruitment. The aim of this study was to investigate the effect on recruitment of optimised patient information materials (with improved readability and ease of comprehension) compared with standard materials. The study was embedded within two primary care trials involving patients with long-term conditions. Methods The Healthlines Study involves two linked trials evaluating a telehealth intervention in patients with depression (Healthlines Depression) or raised cardiovascular disease risk (Healthlines CVD). We conducted two trials of a recruitment intervention, embedded within the Healthlines host trials. Patients identified as potentially eligible in each of the Healthlines trials were randomised to receive either the original patient information materials or optimised versions of these materials. Primary outcomes were the proportion of participants randomised (Healthlines Depression) and the proportion expressing interest in taking part (Healthlines CVD). Results In Healthlines Depression (n = 1364), 6.3 % of patients receiving the optimised patient information materials were randomised into the study compared to 4.0 % in those receiving standard materials (OR = 1.63, 95 % CI = 1.00 to 2.67). In Healthlines CVD (n = 671) 24.0 % of those receiving optimised patient information materials responded positively to the invitation to participate, compared to 21.9 % in those receiving standard materials (OR = 1.12, 95 % CI = 0.78 to 1.61). Conclusions Evidence from these two embedded trials suggests limited benefits of optimised patient information materials on recruitment rates, which may only be apparent in some patient populations, with no effects on other outcomes. Further embedded trials are needed to provide a more precise estimate of effect, and to explore further how effects vary by trial context, intervention, and patient population. Trial registration Current Controlled Trials: Healthlines Depression ( ISRCTN27508731 ) on 26 June 2012; and Healthlines CVD ( ISRCTN14172341 ) on 5 July 2012
机译:背景患者对研究信息的理解是获得知情同意以参加随机对照试验的基础。为了满足研究伦理委员会的要求,患者信息材料可能很长,并且需要传达复杂的信息。令人担忧的是,提供患者信息的标准方法可能会阻止潜在的参与者参加试验。辅助招募的系统技术(MRC-START)研究计划旨在测试干预措施,以改善招募人数。这项研究的目的是研究与标准材料相比,优化的患者信息材料(具有提高的可读性和易理解性)对招聘的影响。该研究被纳入两项涉及长期病情患者的初级保健试验中。方法健康线研究涉及两项相关联的试验,评估对抑郁症(Healthlines Depression)或心血管疾病风险升高(Healthlines CVD)的患者进行远程医疗干预。我们在Healthlines主机试验中进行了两项招募干预试验。在每项Healthlines试验中被确定为潜在合格的患者被随机分配,以接收原始患者信息材料或这些材料的优化版本。主要结局是随机分配的参与者比例(健康线抑郁)和表示有兴趣参加的比例(健康线CVD)。结果在“健康线抑郁症”(n = 1364)中,接受优化患者信息材料的患者中有6.3%被随机分配到研究中,而接受标准材料的患者为4.0%(OR = 1.63,95%CI = 1.00至2.67)。在Healthlines CVD中(n = 671),接受最佳患者信息材料的患者中有24.0%的人对参加邀请有积极的反应,而接受标准材料的患者中有21.9%(OR = 1.12,95%CI = 0.78至1.61)。结论两项嵌入式试验的证据表明,优化患者信息材料对招募率的益处有限,这仅在某些患者人群中可见,而对其他结局无影响。需要进行进一步的嵌入式试验,以提供更准确的疗效评估,并进一步探讨疗效如何随试验背景,干预措施和患者人群而变化。试验注册当前的对照试验:2012年6月26日健康状况低下(ISRCTN27508731);和Healthlines CVD(ISRCTN14172341)于2012年7月5日

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号